Patients with early-stage breast cancer who had a pathologic complete response (pCR) to neoadjuvant chemotherapy may be able to skip surgery and receive standard radiation treatment with a low chance of disease recurrence, according to a new study.
from Women's Health News -- ScienceDaily https://ift.tt/ipS4xRC
0 comments:
Post a Comment